XXII Changing the worlds Cigarette market to a safer place!! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XXII Changing the worlds Cigarette market to a safer place!!

XXII 1.530

+5.5%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

From: Time2shine

2/12/2014 7:42:00 PM

of 56

2014 Current NewsFebruary 11, 201422nd Century Group Files For NYSE MKT Listing and NASDAQ Capital Market Listing ( via Business Wire)
Download PDF document

February 3, 201422nd Century Group Delivers Additional Proprietary Research Cigarettes with Various Nicotine Levels ( via Business Wire)
Download PDF document

January 30, 201422nd Century Group Files Annual Report and Provides Business Update ( via Business Wire)
Download PDF document

XXII

3.19

+0.18

+5.98%

Home / Profile
Profile22nd Century Group, Inc.

22nd Century is a plant biotechnology company whose proprietary technology allows for the level of nicotine (and other nicotinic alkaloids) in the tobacco plant to be decreased or increased through genetic engineering and breeding. For example, one of the 22nd Century’s tobacco varieties has 95% less nicotine than the tobacco found in typical “light” cigarettes. The company owns or exclusively controls 112 issued patents in 78 countries where at least 75% of the world’s smokers reside. 22nd Century’s business segments are primarily smoking cessation products and modified risk tobacco products.